FORTIS.NS Balance Sheet
Fortis Healthcare Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 8 years on file
(FY2018-19 to FY2025-26)
· fetched 2026-08-24 01:36
| Line item | FY2018-19 | FY2019-20 | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|---|---|
| Property, Plant and Equipment | N/A | N/A | N/A | N/A | ₹4,849.56 Cr. | ₹5,267.57 Cr. | ₹5,848.15 Cr. | ₹5,347.88 Cr. | PropertyPlantAndEquipment |
| Capital Work-in-Progress | N/A | N/A | N/A | N/A | ₹227.74 Cr. | ₹540.45 Cr. | ₹403.91 Cr. | ₹432.33 Cr. | CapitalWorkInProgress |
| Goodwill | N/A | N/A | N/A | N/A | ₹4,140.99 Cr. | ₹4,194.16 Cr. | ₹4,194.16 Cr. | ₹4,721.26 Cr. | Goodwill |
| Other Intangible Assets | N/A | N/A | N/A | N/A | ₹435.84 Cr. | ₹411.93 Cr. | ₹381.47 Cr. | ₹621.08 Cr. | OtherIntangibleAssets |
| Non-current Investments | N/A | N/A | N/A | N/A | ₹0.00 Cr. | ₹0.12 Cr. | ₹0.12 Cr. | ₹0.12 Cr. | NoncurrentInvestments |
| Other Non-current Assets | N/A | N/A | N/A | N/A | ₹86.58 Cr. | ₹78.99 Cr. | ₹154.36 Cr. | ₹1,037.21 Cr. | OtherNoncurrentAssets |
| Total Non-current Assets | N/A | N/A | N/A | N/A | ₹10,345.46 Cr. | ₹11,096.68 Cr. | ₹11,527.03 Cr. | ₹14,146.81 Cr. | NoncurrentAssets |
| Inventories | N/A | N/A | N/A | N/A | ₹122.84 Cr. | ₹107.42 Cr. | ₹115.30 Cr. | ₹135.27 Cr. | Inventories |
| Trade Receivables | N/A | N/A | N/A | N/A | ₹581.61 Cr. | ₹627.83 Cr. | ₹784.49 Cr. | ₹1,043.76 Cr. | TradeReceivablesCurrent |
| Cash and Cash Equivalents | N/A | N/A | N/A | N/A | ₹141.08 Cr. | ₹235.27 Cr. | ₹139.72 Cr. | ₹406.97 Cr. | CashAndCashEquivalents |
| Current Investments | N/A | N/A | N/A | N/A | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹17.29 Cr. | CurrentInvestments |
| Other Current Assets | N/A | N/A | N/A | N/A | ₹49.92 Cr. | ₹47.39 Cr. | ₹51.03 Cr. | N/A | OtherCurrentAssets |
| Total Current Assets | N/A | N/A | N/A | N/A | ₹1,832.09 Cr. | ₹2,191.76 Cr. | ₹2,164.50 Cr. | ₹1,819.42 Cr. | CurrentAssets |
| Total Assets | N/A | N/A | N/A | N/A | ₹12,433.60 Cr. | ₹13,288.78 Cr. | ₹13,691.53 Cr. | ₹15,966.23 Cr. | Assets |
| Equity Share Capital | N/A | N/A | N/A | N/A | ₹754.96 Cr. | ₹754.96 Cr. | ₹754.96 Cr. | ₹754.96 Cr. | EquityShareCapital |
| Other Equity | N/A | N/A | N/A | N/A | ₹6,487.30 Cr. | ₹6,907.94 Cr. | ₹8,161.56 Cr. | ₹9,140.59 Cr. | OtherEquity |
| Equity Attributable to Owners | N/A | N/A | N/A | N/A | ₹7,242.26 Cr. | ₹7,662.90 Cr. | ₹8,916.52 Cr. | ₹9,895.55 Cr. | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | N/A | N/A | N/A | N/A | ₹858.13 Cr. | ₹893.24 Cr. | ₹252.87 Cr. | ₹272.96 Cr. | NonControllingInterest |
| Total Equity | N/A | N/A | N/A | N/A | ₹8,100.39 Cr. | ₹8,556.14 Cr. | ₹9,169.39 Cr. | ₹10,168.51 Cr. | Equity |
| Long-term Borrowings | N/A | N/A | N/A | N/A | ₹754.85 Cr. | ₹740.85 Cr. | ₹2,311.32 Cr. | ₹2,401.16 Cr. | BorrowingsNoncurrent |
| Total Non-current Liabilities | N/A | N/A | N/A | N/A | ₹2,907.33 Cr. | ₹1,562.47 Cr. | ₹2,914.82 Cr. | ₹3,676.46 Cr. | NoncurrentLiabilities |
| Short-term Borrowings | N/A | N/A | N/A | N/A | ₹170.87 Cr. | ₹117.45 Cr. | ₹163.78 Cr. | ₹471.49 Cr. | BorrowingsCurrent |
| Trade Payables | N/A | N/A | N/A | N/A | ₹714.29 Cr. | ₹727.79 Cr. | ₹807.62 Cr. | ₹943.12 Cr. | TradePayablesCurrent |
| Other Current Liabilities | N/A | N/A | N/A | N/A | ₹160.36 Cr. | ₹211.41 Cr. | ₹163.79 Cr. | ₹509.88 Cr. | OtherCurrentLiabilities |
| Total Current Liabilities | N/A | N/A | N/A | N/A | ₹1,313.56 Cr. | ₹3,170.17 Cr. | ₹1,607.32 Cr. | ₹2,121.26 Cr. | CurrentLiabilities |
| Total Equity and Liabilities | N/A | N/A | N/A | N/A | ₹12,433.60 Cr. | ₹13,288.78 Cr. | ₹13,691.53 Cr. | ₹15,966.23 Cr. | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from FORTIS.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).